Medical Properties Trust, Inc. is classed by the SEC under Real Estate Investment Trusts (industry code 6798), based in Birmingham, AL. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $972 million and a loss of $277 million (its filed statements).
Property businessReal Estate Investment TrustsBirmingham, ALfilings since 20049 of 9 filed
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a property business: prior from its industry code (SEC 6798, Real Estate Investment Trusts); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
The grade, in three tenses
Headline 4.2 out of ten, 9 of 9 metrics filed: past 2.4 out of ten, present 4.3 out of ten, future 5.5 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
The nine metrics
Surviving crises (past): 0.8 out of ten. 2 warning events since 2017; the latest 2024-05-16. 8th percentile among 174 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Track record (past): 3.6 out of ten. +6.7% a year over 10 filed years; profitable in 7 of 10. 36th percentile among 156 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Shareholder treatment (past): 4.0 out of ten. Share count grew 0.1% a year. 2% of cash flow returned. Insiders: 2 sales, 1 purchases. 40th percentile among 156 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Financial health (present): 3.5 out of ten. ROE -6%: lost 6¢ per shareholder dollar. Leverage 69%: owes 69¢ per asset dollar. 35th percentile among 171 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Industry position (present): 2.5 out of ten. bottom 25% of 157 in its family; net margin -28.5%. 25th percentile among 157 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Leadership (present): 8.5 out of ten. top 15% of 161 in its family for leadership; chief executive since 2006. 85th percentile among 161 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-09).
Room to expand (future): 4.5 out of ten. bottom 45% of 146 in its family for room to expand. 45th percentile among 146 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Growth drivers (future): 1.7 out of ten. bottom 17% of 153 in its family for growth drivers. 17th percentile among 153 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
Expectations vs reality (future): 8.8 out of ten. top 12% of 150 in its family for expectations against reality. 88th percentile among 150 sector filers. A production reading, recomputed from the filings on every data build (read from EDGAR 2026-10-12).
The filing record
Newest annual report: Form 10-K filed 2026-02-26 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-10 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-10 (on EDGAR). Newest filing: Form 4, 2026-10-07. Filings on record since 2004. Read from EDGAR 2026-10-12.
Who runs it
Aldag, Edward K Jr (Chairman, President & CEO); Portal, Larry H (SVP, Senior Advisor to the CEO); Hamner, R Steven (Executive Vice President & CFO); Hanna, James Kevin (Senior VP, Controller & CAO); Hooper, Rosa Handley (SVP of Operations); Lambert, Charles R (SVP of Finance and Treasurer); Stewart, Michael G (EVP and General Counsel); Dawson, G Steven (director); Mozingo, Caterina Ardon (director); Murphy, Emily Webster (director); and 3 more. 13 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-10-07.
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.